Walang himala! Ang himala ay nasa puso ng tao, nasa puso nating lahat!” remains one of the most powerful lines ever spoken in ...

Ako Bicol party-list on Wednesday reclaimed the House seat earlier vacated by resigned lawmaker Zaldy Co after the Commission on Elections (Comelec) proclaimed its third nominee, lawyer Jan Franz ...

MANILA, Philippines — The National Bureau of Investigation (NBI) on Wednesday clarified its limitations in tracking the whereabouts of Ako Bicol Party-list Representative Zaldy Co, emphasizing that ...

Contingency Planning Memoranda identify plausible scenarios that could have serious consequences for U.S. interests and propose measures to both prevent and mitigate them. Tensions have risen to ...

Gloc-9 has mixed feelings about his 16-year-old socially charged song, Upuan, going viral amid public outrage over alleged corruption in flood control projects. Released in 2009, the hip-hop track ...

Hong Kong developer Sino Land on Wednesday said its net profit for the financial year that ended on June 30 fell from a year earlier as strong residential sales were offset by lower rental income and ...

If you want to know what is driving today's China or America, Chinese-Canadian analyst Dan Wang's new book is an indispensable guide. Wang shows that the world’s most urgent and challenging ...

About a month after her resurfaced “Sino Nga Ba Siya” cover went viral on social media, Mika Salamanca released her official version of the Sarah Geronimo song. Salamanca’s rendition was released by ...

Sino Biopharmaceutical, a major Hong Kong–listed biotech, is set to acquire the remaining 95.09% of Shanghai’s LaNova Medicines for up to US $950.9 million, completing a full takeover pending ...

July 15 (Reuters) - Hong Kong-listed Sino Biopharmaceutical (1177.HK), opens new tab said on Tuesday it will buy the remaining 95.09% stake it does not hold in Shanghai-based LaNova Medicines for no ...

The PD-1xVEGF dealmaking wave that has captivated Western pharma companies is now surging within China. Tuesday, Sino Biopharmaceutical said it will pay up to $951 million to acquire Chinese ...

Hong Kong-listed Sino Biopharmaceutical will acquire China-based oncology specialist LaNova Medicines in a deal that will not exceed $951m, representing one of the largest transactions within the Asia ...